Kerstin Herzer

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 5

Top Topics

Prognostic Factors

Cell Proliferation

Hepatitis C Virus

End Stage Renal Disease

Top Venues

Transplant infectious disease : an official journal of the Transplantation Society

Clinical transplantation

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jassin Rashidi-Alavijeh, Jens Christoph Crämer, Helena Louisa Sauter, Katharina Willuweit, Katja Straub, Heiner Wedemeyer, Kerstin Herzer
Primary sclerosing cholangitis as an independent risk factor for cytomegalovirus infection after liver transplant. Transplant infectious disease : an official journal of the Transplantation Society 23 (3) (2021)
Jassin Rashidi-Alavijeh, Katja Straub, Anne Achterfeld, Heiner Wedemeyer, Katharina Willuweit, Kerstin Herzer
Safety and efficacy of tenofovir alafenamide in liver transplant recipients: A single center experience. Transplant infectious disease : an official journal of the Transplantation Society 23 (3) (2020)
Katja Straub, Peri Husen, Hideo A Baba, Martin Trippler, Heiner Wedemeyer, Kerstin Herzer
Promyelocytic leukemia protein deficiency leads to spontaneous formation of liver tumors in hepatitis C virus transgenic mice. Cancer medicine 8 (8) (2019)
Justa Friebus-Kardash, Anja Gäckler, Andreas Kribben, Oliver Witzke, Heiner Wedemeyer, Jürgen Treckmann, Kerstin Herzer, Ute Eisenberger
Successful early sofosbuvir-based antiviral treatment after transplantation of kidneys from HCV-viremic donors into HCV-negative recipients. Transplant infectious disease : an official journal of the Transplantation Society 21 (5) (2019)
Katharina Willuweit, Andreas Heinold, Jassin Rashidi-Alavijeh, Falko M Heinemann, Peter A Horn, Andreas Paul, Guido Gerken, Kerstin Herzer
Immunosuppression with mTOR inhibitors prevents the development of donor-specific antibodies after liver transplant. Clinical transplantation 31 (6) (2017)